Interaction with important neurotransmitter transporters has been characterized for a lignan derivative (−)-cubebin, and (−)-hinokinin, and the results obtained to date suggest that hinokinin can serve as a tool to develop new therapeutic anxiety drugs that target dopamine, norepinephrine, and GABA transporters [85]. Here, SLC6A2 is linked to Anxiety.